Overview
A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.
Indication
用于体表创伤、外科创面止血及上消化道出血。
Associated Conditions
- Vaginal burning sensation
- Vaginal itching
Research Report
Microcrystalline Cellulose (DB14158): A Comprehensive Monograph on its Physicochemical Properties, Multifaceted Applications, and Formulation Science
Executive Summary
Microcrystalline Cellulose (MCC) is a purified, partially depolymerized form of cellulose, a naturally occurring polymer sourced from fibrous plant materials such as high-grade wood pulp.[1] Identified as a small molecule with DrugBank ID DB14158 and CAS Number 9004-34-6, MCC has established itself as one of the most versatile and indispensable excipients in the pharmaceutical industry.[1] It is particularly prized for its exceptional binding capabilities and compressibility, which are foundational to modern tablet manufacturing, especially the efficient direct compression method.[5] Beyond pharmaceuticals, its unique properties have led to widespread use in the food, cosmetic, and other industrial sectors.[7] The extensive utility of MCC is underpinned by an excellent safety profile, affirmed by its "Generally Recognized as Safe" (GRAS) status from the U.S. Food and Drug Administration (FDA) and its acceptance by global regulatory bodies.[10] A key attribute of MCC is its pharmacokinetic inertness; it is not absorbed or metabolized by the body, a critical feature for an excipient designed to have no pharmacological effect of its own.[3] This report provides a detailed examination of MCC, elucidating how its material science—from the specifics of its manufacturing process to its fundamental physicochemical properties like crystallinity and particle size—dictates its multifunctional performance across a vast array of applications.
Chemical Identity and Physicochemical Profile
Nomenclature, Structure, and Identification
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2023/10/05 | Phase 2 | Recruiting | |||
2023/08/25 | Phase 2 | Terminated | |||
2023/06/29 | Not Applicable | Completed | Minia University | ||
2023/06/18 | Phase 2 | Withdrawn | |||
2023/04/24 | Phase 3 | Completed | |||
2023/04/20 | Phase 4 | Completed | |||
2023/04/12 | Phase 4 | Completed | |||
2023/04/03 | Phase 3 | Completed | |||
2022/07/28 | Phase 1 | Completed | |||
2022/05/06 | Phase 4 | Not yet recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
Ativan 1mg - South Africa | 373706 | Medicine | A | 8/27/2021 | |
Doryx 60mg Tablet | 393210 | Medicine | A | 8/1/2022 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
No Health Canada approvals found for this drug. |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.